Rare epilepsy syndrome
Conditions
Interventions
None listed
Sponsors
NHO Shizuoka Institute of Epilepsy and Neurological Disorders
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Early myoclonic encephalopathy Ohtahara syndrome Epilepsy of infancy with migrating focal seizures West syndrome Dravet syndrome Myoclonic status in nonprogressive encephalopathy Epilepsy with myoclonic atonic seizures Epilepsy with myoclonic absences Lennox-Gastaut syndrome Epileptic encephalopathy with continuous spike-and-wave during sleep (Electrical Status Epilepticus during Slow Sleep) Landau-Kleffner syndrome Progressive myoclonus epilepsies Mesial temporal lobe epilepsy with hippocampal sclerosis Rasmussen syndrome Gelastic seizures with hypothalamic hamartoma Hemiconvulsion-hemiplegia-epilepsy syndrome Aicardi syndrome Angelman syndrome Rett syndrome PCDH19-related epilepsy in females Ring 20 chromosome syndrome Focal epilepsy NOS Generalized epilepsy NOS Undetermined epilepsy NOS
Exclusion criteria
Exclusion criteria: When attending physician considers the patient inappropriate to include in the study. When there is no causative disorder in case of focal epilepsy NOS, generalized epilepsy NOS or Undetermined epilepsy NOS. When the onset date of epilepsy is uncertain.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Death, intellectual development, neuro-psychiatric status, comorbid condition, seizure type and seizure frequency, EEG and imaging findings, treatment, psychosocial condition. Evolutional changes of developmental status, seizure type and frequency, laboratory findings, social status as well as overall condition during the several years after onset. | — |
Countries
Japan
Contacts
Public ContactYushi Inoue
NHO Shizuoka Institute of Epilepsy and Neurological Disorders Clinical Research Division
Outcome results
None listed